Boston Scientific Corp
(WBO:BSXC)
€
86
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 70/100 Boston Scientific Corp at Bank of America Healthcare Conference Transcript
May 12, 2022 / 03:00PM GMT
Release Date Price:
€37.22
(-0.55%)
Travis Lee Steed
BofA Securities, Research Division - MD
On our last day of the conference, we welcome to join Boston Scientific. Dan Brennan; and Lauren Tengler, VP of IR, welcome.
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Thanks so much for the invitation, Travis. A pleasure to be here. Thank you.
Lauren Tengler
Boston Scientific Corporation - Director of IR
Thank you.
Questions & Answers
Travis Lee Steed;Daniel J.
BofA Securities, Research Division - MD
So Dan, I just wanted to start out, first, thinking through like the Q1 performance and March recovery. Like we've been talking to a lot of companies this week, and it seems like for most of the elective names, March, strong; April, even for some companies, similar to March or better for March and that's continued into May. Seems like elective recovery's well on track. But I'd love to get your thoughts on kind of what you're seeing around your portfolio.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot